Provenance Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Hold |
200
| – | – | 0.02% | 162 |
|
|
2025
Q1 | $127K | Hold |
200
| – | – | 0.02% | 164 |
|
|
2024
Q4 | $142K | Hold |
200
| – | – | 0.02% | 166 |
|
|
2024
Q3 | $210K | Hold |
200
| – | – | 0.03% | 151 |
|
|
2024
Q2 | $210K | Hold |
200
| – | – | 0.03% | 137 |
|
|
2024
Q1 | $192K | Hold |
200
| – | – | 0.03% | 148 |
|
|
2023
Q4 | $176K | Hold |
200
| – | – | 0.02% | 133 |
|
|
2023
Q3 | $165K | Buy |
+200
| New | +$165K | 0.03% | 126 |
|